Underwood Capital Limited · ASX:UWC
Underwood Capital — Investor Presentation (November 2018)
9 slides from Underwood Capital's investor presentation, Nov 21, 2018
Slide 1: Investor Presentation
Investor Presentation 21 November 2018 © 2018 MMJ Group Holdings Limited | ASX: MMJ | www.mmjgh.com.au
Slide 2: MMJ Group Holdings Limited
MMJ Group Holdings Limited Global cannabis investment company Corporate Details Portfolio Investment Approach ASX: MMJ 10 minority investments Invest across the value chain Listed investment company (“LIC”); to be reinstated to (2 public; 8 private) official quotation by the ASX tomorrow Minority st
Slide 3: Portfolio currently focused on North America
Portfolio currently focused on North America Recreational cannabis sales were legalised in Canada in October 2018 Country of Origin Investee TSXV:HVT TSXV:LABS Hemp- Retail Business Brands Extraction Cultivation Extraction Beverages R&D derived Clinics Extraction Stores CBD % of AUM 50% 17% 11% 5% 5
Slide 4: North American target markets are attractive
North American target markets are attractive Large markets for recreational cannabis and hemp-derived CBD products 2019 Forecast Source: Deloitte 2018 cannabis report “A society in transition, an industry ready to bloom”. Projected legal market size is based on forecast sales for the whole market in
Slide 5: Portfolio company leadership is impressive
Portfolio company leadership is impressive Experienced and highly motivated senior executives with strong track records Bruce Dawson- Dr Sanjay Nelson Grant Froese Pat McCutcheon Ed Jamieson Trevor Fencott Marcello Leone Curtis Leifso Ram Venkat Scully Nijhawan Reynolds 38-year career 15-years in th
Slide 6: Investments sit across most of the value chain
Investments sit across most of the value chain Capital is allocated to potential market leaders, consolidators and takeover targets Genetics Crystallisation Product Cultivation Extraction Testing Packaging Distribution Retail Patient and Seeds and R&D manufacture Not a current Potential Not a curren
Slide 7: Capital allocation is actively managed
Capital allocation is actively managed Currently skewed to cannabis brands and extraction facilities Capital Allocation Warrants Exercise cost Current Brands Warrants held by MMJ Warrants of warrants Unrealised Gain Unaudited figures expiry Extraction (CAD$m) (CAD$m) MediPharm Labs (TSXV:LABS) $ 3.5
Slide 8: Outlook is positive
Outlook is positive Significant developments are expected across the portfolio Investee Outlook for the next 12 months • Cultivation capacity: targeting 20,000 kg per annum of owned cannabis cultivation capacity by the end of the 2019 calendar year • Satipharm: annual revenue run-rate of CAD$10 mill
Slide 9: Disclaimer
Disclaimer DISCLAIMER FUTURE MATTERS This presentation has been prepared by MMJ Group Holdings Limited (the “Company” or “MMJ”) This presentation contains reference to certain intentions, expectations, future plans, strategy and (ABN 91 601 236 417). It does not purport to contain all the informatio
Underwood Capital — Investor Presentation (November 2018) on 6ix